prohibited list is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
A sarcomere is defined as the segment between two neighbouring Z-lines (or Z-discs). In electron micrographs of cross-striated muscle, the Z-line (from the German "zwischen" meaning between) appears in between the I-bands as a dark line that anchors the actin myofilaments. Surrounding the Z-line is the region of the I-band (for isotropic). I-band is the zone of thin filaments that is not superimposed by thick filaments (myosin). Following the I-band is the A-band (for anisotropic). Named for their properties under a polarized light microscope. An A-band contains the entire length of a single thick filament. The anisotropic band contains both thick and thin filaments. Within the A-band is a paler region called the H-zone (from the German "heller", brighter). Named for their lighter appearance under a polarization microscope. H-band is the zone of the thick filaments that has no actin. Within the H-zone is a thin M-line (from the German "mittel" meaning middle), appears in the middle of the sarcomere formed of cross-connecting elements of the cytoskeleton.
In the US the first large-scale use of cement was Rosendale cement, a natural cement mined from a massive deposit of dolomite discovered in the early 19th century near Rosendale, New York. Rosendale cement was extremely popular for the foundation of buildings (e.g., Statue of Liberty, Capitol Building, Brooklyn Bridge) and lining water pipes. Sorel cement, or magnesia-based cement, was patented in 1867 by the Frenchman Stanislas Sorel. It was stronger than Portland cement but its poor water resistance (leaching) and corrosive properties (pitting corrosion due to the presence of leachable chloride anions and the low pH (8.5–9.5) of its pore water) limited its use as reinforced concrete for building construction. The next development in the manufacture of Portland cement was the introduction of the rotary kiln. It produced a clinker mixture that was both stronger, because more alite (C3S) is formed at the higher temperature it achieved (1450 °C), and more homogeneous. Because raw material is constantly fed into a rotary kiln, it allowed a continuous manufacturing process to replace lower capacity batch production processes.
The axonal transport system carries material along the axon in both directions (anterograde and retrograde) at different speeds (fast and slow). The fast transport travels at up to 400 mm/day. The slow transport is less than 8 mm/day. During compression not severe enough to cause axonmetesis (not destroy the axon), the axons will maintain their structural integrity but experience degraded function in the axonal transport systems. Studies have found that pressures as low as 30mmHg can impair axonal transport. The double-crush theory originally referred to anterograde axonal transport. For example, a spinal compressive lesion was posited to increase susceptibility to more distal compressive lesions like carpal tunnel. There is a complimentary reverse double-crush theory which refers to retrograde axonal transport.
==== Comorbid personality disorders ==== Approximately 74% of individuals with BPD also fulfill criteria for another personality disorder during their lifetime, according to research published in 2008. The most prevalent co-occurring disorders are from Cluster A (paranoid, schizoid, and schizotypal personality disorders), affecting about half of those with BPD, with schizotypal personality disorder alone impacting one-third of individuals. Being part of Cluster B, BPD patients also commonly share characteristics with other Cluster B disorders (antisocial, histrionic, and narcissistic personality disorders), with nearly half of individuals with BPD showing signs of these conditions, and narcissistic personality disorder affecting roughly one-third. Cluster C disorders (avoidant, dependent, and obsessive-compulsive personality disorders) have the least comorbidity with BPD, with just under a third of individuals with BPD meeting the criteria for a Cluster C disorder.
As part of Operation Typhoon, the 4th Panzer Group was subordinated to the 4th Army under the command of Günther von Kluge. In early October, the 4th Panzer Group completed the encirclement at Vyazma. Kluge instructed Hoepner to pause the advance, much to the latter's displeasure, as his units were needed to prevent break-outs of Soviet forces. Hoepner was confident that the clearing of the pocket and the advance on Moscow could be undertaken at the same time and viewed Kluge's actions as interference, leading to friction and "clashes" with his superior, as he wrote in a letter home on 6 October. Hoepner did not seem to appreciate that his units were very short on fuel; the 11th Panzer Division, reported having no fuel at all. Only the 20th Panzer Division was advancing towards Moscow amid deteriorating road conditions. Once the Vyazma pocket was eliminated, other units were able to advance on 14 October. Heavy rains and onset of the rasputitsa (roadlessness) caused frequent damage to tracked vehicles and motor transport further hampering the advance. By early November, the 4th Panzer Group was depleted from earlier fighting and the weather but Hoepner, along with other panzer group commanders and Fedor von Bock, commander of Army Group Center, was impatient to resume the offensive. On 17 November, the 4th Panzer Group attacked again towards Moscow alongside the V Army Corps of the 4th Army, as part of the continuation of Operation Typhoon by Army Group Centre. The panzer group and the army corps represented Kluge's best forces, most ready for a continued offensive.
Sources: en.wikipedia.org
MRI uses powerful magnets and can therefore cause magnetic materials to move at great speeds, posing a projectile risk, and may cause fatal accidents. However, as millions of MRIs are performed globally each year, fatalities are extremely rare. MRI machines can produce loud noise, up to 120 dB(A). This can cause hearing loss, tinnitus and hyperacusis, so appropriate hearing protection is essential for anyone inside the MRI scanner room during the examination.
Between 1961 and 1965, Rhodesia took in an average of 8,225 white immigrants per year while also having an average white emigration of 12,912 per year. Many prospective white immigrants in Rhodesia arrived seeking economic opportunities and departed with fluctuations in the security situation as the Bush War intensified. A substantial number were uninterested in settling there permanently and did not apply for Rhodesian citizenship, despite a much-publicised 1967 campaign urging them to do so. Brownell asserted that patriotism in the white community was "shallow" due to its essentially expatriate character. He also claimed that the majority of white immigrants in the late 1960s and early 1970s were unskilled labourers who competed with the country's black African workforce and did not contribute badly needed technical or professional skills to the country, arguing that this was due to government policy aimed at making white immigration as "unselective as possible" and guaranteeing every white immigrant a job. The population of Rhodesia boomed during the late 1960s due to immigration and an exceptional rate of natural increase among its black citizens, the highest in sub-Saharan Africa at the time.
Scorpions are sometimes kept as pets, in the same way as other dangerous animals like snakes and tarantula spiders. Popular Science Monthly carried an article entitled "My pet scorpion" as early as 1899.
It is a neuropsychiatric disorder, so besides the motor problems there is classically emotional lability (mood swings, or inappropriate mood), but also tics, anxiety, attention deficit etc. These can precede the motor symptoms. Non-neurologic manifestations of acute rheumatic fever may be present, namely carditis (up to 70% of cases, often subclinical, so echocardiography required), arthritis, erythema marginatum, and subcutaneous nodules.
{\displaystyle {\frac {U_{e}}{AL_{0}}}={\frac {E\,{\Delta L}^{2}}{2L_{0}^{2}}}={\frac {1}{2}}\times {\frac {E\,{\Delta L}}{L_{0}}}\times {\frac {\Delta L}{L_{0}}}={\frac {1}{2}}\times \sigma (\varepsilon )\times \varepsilon }
Sources: en.wikipedia.org
=== Yugoslavia === On 29 November 1945, the Federal People's Republic of Yugoslavia was proclaimed. It was under Soviet influence in the final months of the war and the first few post-war years, Stalin declared it outside the Soviet sphere of interest on several occasions, treating it like a satellite state. The contrast with the rest of Eastern Europe was underscored ahead of a Soviet offensive in October 1944. Tito's Partisans supported the offensive, which ultimately pushed the Wehrmacht and its allies out of northern Serbia and captured Belgrade. Marshal Fyodor Tolbukhin's Third Ukrainian Front had to request formal permission from Tito's provisional government to enter Yugoslavia and had to accept Yugoslav civil authority in any liberated territory. which maintained its claims against Italy and Austria. The territorial dispute in the northwest part of Istria peninsula and around the city of Trieste caused the Treaty of Peace with Italy to be delayed until 1947, and establishment of the independent Free Territory of Trieste. This did not satisfy Tito as he sought revisions of the borders around Trieste and in Carinthia prompting the Western Allies to keep a garrison in Trieste to prevent Yugoslav takeover. Tito's continued insistence on acquisition of Trieste was also seen by Stalin as an embarrassment to the Italian Communist Party.
== Structure == MCH is a cyclic 19-amino acid neuropeptide, as it is a polypeptide chain that is able to act as a neurotransmitter. MCH neurons are mainly concentrated in the lateral hypothalamic area, zona incerta, and the incerto-hypothalamic area, but they are also located, in much smaller amounts, in the paramedian pontine reticular formation (PPRF), medial preoptic area, laterodorsal tegmental nucleus, and the olfactory tubercle. MCH is activated by binding to two G-coupled protein receptors (GCPRs), MCHR1 and MCHR2. MCHR2 has only been identified in certain species such as humans, dogs, ferrets, and rhesus monkeys, while other mammals such as rodents and rabbits do not have the receptor. MCH is cleaved from prepro-MCH (ppMCH), a 165 amino acid polypeptide which also contains the neuropeptides GE and EI.
Ever since the appearance and spread of rival organizations during the late 80s to the early 90s (both in Rio and other states), CV has waged major turf wars against other cartels and street gangs. In recent years it has been involved in a series of prison riots, massacres and territorial conflicts thorough the entire country, which resulted in dozens (or sometimes even hundreds) of casualties, mostly involving police militias (which have grown considerably in the past decade) and rival gangs such as ADA, GDE and TCP. After negotiations for an "alliance" with São Paulo–based PCC broke down in 2016 (mainly due to disputes between shared drugs and arms trafficking routes in Paraguay, Bolivia and Colombia), a series of retaliations (which included mass shootings, executions and invasions of rival favelas) broke out between both groups and their allies, which have resulted in severe casualties, including not only gang members but also many innocent civilians and security officials who have been caught in the crossfire. However, despite years of violent conflicts with the Brazilian police and other criminal organizations, as well as deterrent efforts such as the Police Pacifying Unit (UPP) and the occupation of several favelas, the CV maintains significant power and governance in many of Rio de Janeiro's favelas, and, like many other organizations, has increasingly been portrayed as a "cultural icon" in some genres of Brazilian music (such as in the Proibidão, Ostentação and Automotivo sub-genres of Brazilian funk, Trap and Hip-Hop).
=== Synthetic Biology === CRISPR – faster and more efficient gene editing technique Gene delivery/gene therapy – designing molecules to deliver modified or new genes into cells of live organisms to cure genetic disorders Metabolic engineering – modifying metabolism of organisms to optimize production of chemicals (e.g. synthetic genomics) Protein engineering – altering structure of existing proteins to enable specific new functions, or the creation of fully artificial proteins DNA-functionalized materials – 3D assemblies of DNA-conjugated nanoparticle lattices
Delirium has been noted from discontinuation from clorazepate. A benzodiazepine dependence occurs in approximately one third of patients who take benzodiazepines for longer than 4 weeks, which is characterised by a withdrawal syndrome upon dose reduction. When used for seizure control, tolerance may manifest itself with an increased rate of seizures as well an increased risk of withdrawal seizures. In humans, tolerance to the anticonvulsant effects of clorazepate occurs frequently with regular use. Due to the development of tolerance, benzodiazepines are, in general, not considered appropriate for the long-term management of epilepsy; increasing the dose may result only in the developing of tolerance to the higher dose combined with worsened adverse effects. Cross-tolerance occurs between benzodiazepines, meaning that, if individuals are tolerant to one benzodiazepine, they will display a tolerance to equivalent doses of other benzodiazepines. Withdrawal symptoms from benzodiazepines include a worsening of pre-existing symptoms as well as the appearance of new symptoms that were not pre-existing. The withdrawal symptoms may range from mild anxiety and insomnia to severe withdrawal symptoms such as seizures and psychosis. Withdrawal symptoms can be difficult in some cases to differentiate between pre-existing symptoms and withdrawal symptoms. Use of high doses, long-term use and abrupt or over-rapid withdrawal increase the severity of withdrawal syndrome. However, tolerance to the active metabolite of clorazepate may occur more slowly than with other benzodiazepines.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.